החברה הישראלית לנוירואימונולוגיה

The Israel society of Neuroimmunology

הצטרפות תיעוד כנסים מרכזים נוירואימונולוגיים הנחיות וניירות עמדה השתלמויות מידע לציבור תיאורי מקרה בעלי תפקידים

יו"ר: תמיר בן-חור
מזכיר: מרק הלמן
גזבר: פניוטה פטרו
חברי הוועד: אסתר גנלין-כהן, אלון מונסונגו, דן פרנקל, יואב צ'פמן, הדר קולב, אלה שיפרין-בוניאק
נשיא כבוד: עודד אברמסקי

מן הרשת

עמוד 1 מתוך 3
1
2
3
>

19.10.2023

14:26

Multiple Sclerosis-Associated Gut Microbiome in the Israeli Diverse Populations

Associations with Ethnicity, Gender, Disability Status, Vitamin D Levels, and Mediterranean Diet

Int J Mol Sci

19.10.2023

14:20

Clinical features of myasthenia gravis with neurological and systemic autoimmune diseases

We reviewed autoimmune diseases in MG to explore their clinical presentations and determine whether the presence of autoimmune diseases affects the disease severity and treatment strategies for MG

Frontiers in Immunology

19.10.2023

14:13

Personality Traits and Fatigue in Multiple Sclerosis

A Narrative Review

J Clin Med.

19.10.2023

14:12

Editorial: Fatigue in multiple sclerosis-A current perspective

As editors of this Research Topic, we wanted to acknowledge and give scientific space to a symptom that affects so many patients with multiple sclerosis (MS) and which has an enormous impact on the daily lives of those affected, their vocational status, and social participation

Frontiers in Neurology

19.10.2023

14:07

Paramagnetic rims are a promising diagnostic imaging biomarker in multiple sclerosis

White matter lesions (WMLs) on brain magnetic resonance imaging (MRI) in multiple sclerosis (MS) may contribute to misdiagnosis. In chronic active lesions, peripheral iron-laden macrophages appear as paramagnetic rim lesions (PRLs)

Mult Scler

12.09.2023

11:45

Ageing and multiple sclerosis

The factor that is most relevant and strongly associated with the clinical course of multiple sclerosis is chronological age. Very young patients exclusively have relapsing remitting disease, whereas those with later onset disease face a more rapid development of permanent disability

Lancet Neurol

12.09.2023

11:44

Multiple sclerosis progression: time for a new mechanism-driven framework

Accumulating evidence suggests that the clinical course of multiple sclerosis is better considered as a continuum, with contributions from concurrent pathophysiological processes that vary across individuals and over time

Lancet Neurol

12.09.2023

11:43

A Scoping Review on Body Fluid Biomarkers for Prognosis and Disease Activity in Patients with Multiple Sclerosis

Multiple sclerosis (MS) is a complex demyelinating disease of the central nervous system, presenting with different clinical forms, including clinically isolated syndrome (CIS), which is a first clinical episode suggestive of demyelination

J Pers Med

12.09.2023

11:40

Cerebrospinal fluid biomarkers and cognitive functions at multiple sclerosis diagnosis

Cognitive impairment (CI) is a frequent and disabling symptom in Multiple Sclerosis (MS). Axonal damage may contribute to CI development from early stages. Nevertheless, no biomarkers are at the moment available to track CI in MS patients

J Neurol

12.09.2023

11:39

Personality Traits and Fatigue in Multiple Sclerosis: A Narrative Review

Fatigue is a prevalent and debilitating symptom that significantly impacts the quality of life of these patients. A relationship between personality traits and fatigue in MS has been hypothesized but not clearly defined

J Clin Med

12.09.2023

11:35

Diagnosis and treatment of progressive multiple sclerosis: A position paper

carried out an extensive review of the literature highlighting differences in the definition of progressive forms of MS, and the importance of assessing the extent of the ongoing inflammatory component in MS when making treatment decisions

Eur J Neurol

20.07.2023

13:37

Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain

Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis

JAMA Neurol

20.07.2023

13:36

Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis

a retrospective modelling and validation study

Lancet Neurol

20.07.2023

13:35

How patients with multiple sclerosis acquire disability

This study addresses the relative contribution of relapses to disability worsening over the course of the disease, how early progression begins and the extent to which multiple sclerosis therapies delay disability accumulation

Brain

20.07.2023

13:34

Mesenchymal Stem Cell Transplantation in Progressive Multiple Sclerosis

Effects of Mesenchymal Stem Cell Transplantation on Cerebrospinal Fluid Biomarkers in Progressive Multiple Sclerosis

Stem Cells Translational Medicine

עמוד 1 מתוך 3
1
2
3
>

מחקרים וחדשות רפואה

19.10.2023, 16:25

Israeli National Academy of Science Letter

מערכת MEDNET
מן הרשת

19.10.2023, 14:26

Multiple Sclerosis-Associated Gut Microbiome in the Israeli Diverse Populations

Int J Mol Sci
מן הרשת

19.10.2023, 14:20

Clinical features of myasthenia gravis with neurological and systemic autoimmune diseases

Frontiers in Immunology
מן הרשת

19.10.2023, 14:13

Personality Traits and Fatigue in Multiple Sclerosis

J Clin Med.

יומן ארועים

aaaינואר 2024	דצמבר 2023					נובמבר 2023
א	ב	ג	ד	ה	ו	ש
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30
31

7 הכי נקראות